ASX:JHL

Jayex Healthcare Competitors

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume120,428 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

Jayex Healthcare (ASX:JHL) Vs. 1ST, ALC, BNVIF, CNNA, CNONF, and DOCRF

Should you be buying JHL stock or one of its competitors? Companies in the industry of "health information services" are considered alternatives and competitors to Jayex Healthcare, including 1st Group (1ST), Alcidion Group (ALC), Binovi Technologies (BNVIF), Cann American (CNNA), CannaOne Technologies (CNONF), and CloudMD Software & Services (DOCRF).

1st Group (ASX:1ST) and Jayex Healthcare (ASX:JHL) are both computer and technology companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, dividends, profitability, earnings and risk.

Analyst Ratings

This is a breakdown of current recommendations and price targets for 1st Group and Jayex Healthcare, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
1st Group0000N/A
Jayex Healthcare0000N/A

Earnings & Valuation

This table compares 1st Group and Jayex Healthcare's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
1st Group$5.11 million0.00$-4,246,169.92A($0.01)N/A
Jayex Healthcare$6.61 million0.00$-805,452.03A$0.00N/A

Jayex Healthcare has higher revenue and earnings than 1st Group.

Profitability

This table compares 1st Group and Jayex Healthcare's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
1st GroupN/AN/AN/A
Jayex HealthcareN/AN/AN/A

Summary

Jayex Healthcare beats 1st Group on 3 of the 3 factors compared between the two stocks.

Jayex Healthcare (ASX:JHL) and Alcidion Group (ASX:ALC) are both computer and technology companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, earnings, risk, valuation, analyst recommendations, profitability and institutional ownership.

Analyst Ratings

This is a breakdown of recent ratings and price targets for Jayex Healthcare and Alcidion Group, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Jayex Healthcare0000N/A
Alcidion Group0000N/A

Valuation and Earnings

This table compares Jayex Healthcare and Alcidion Group's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Jayex Healthcare$6.61 million0.00$-805,452.03A$0.00N/A
Alcidion Group$21.55 million0.00$-2,972,082.05A$0.00N/A

Jayex Healthcare has higher earnings, but lower revenue than Alcidion Group.

Profitability

This table compares Jayex Healthcare and Alcidion Group's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Jayex HealthcareN/AN/AN/A
Alcidion GroupN/AN/AN/A

Summary

Alcidion Group beats Jayex Healthcare on 2 of the 3 factors compared between the two stocks.

Jayex Healthcare (ASX:JHL) and Binovi Technologies (OTCMKTS:BNVIF) are both computer and technology companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, analyst recommendations, dividends and valuation.

Analyst Recommendations

This is a breakdown of recent ratings and target prices for Jayex Healthcare and Binovi Technologies, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Jayex Healthcare0000N/A
Binovi Technologies0000N/A

Valuation and Earnings

This table compares Jayex Healthcare and Binovi Technologies' gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Jayex Healthcare$6.61 million0.00$-805,452.03A$0.00N/A
Binovi TechnologiesN/AN/AN/AN/AN/A

Binovi Technologies has lower revenue, but higher earnings than Jayex Healthcare.

Profitability

This table compares Jayex Healthcare and Binovi Technologies' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Jayex HealthcareN/AN/AN/A
Binovi TechnologiesN/AN/AN/A

Summary

Jayex Healthcare beats Binovi Technologies on 1 of the 1 factors compared between the two stocks.

Jayex Healthcare (ASX:JHL) and Cann American (CNSX:CNNA) are both computer and technology companies, but which is the superior investment? We will compare the two businesses based on the strength of their risk, institutional ownership, analyst recommendations, earnings, profitability, dividends and valuation.

Profitability

This table compares Jayex Healthcare and Cann American's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Jayex HealthcareN/AN/AN/A
Cann AmericanN/AN/AN/A

Analyst Ratings

This is a breakdown of current ratings and recommmendations for Jayex Healthcare and Cann American, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Jayex Healthcare0000N/A
Cann American0000N/A

Earnings and Valuation

This table compares Jayex Healthcare and Cann American's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Jayex Healthcare$6.61 million0.00$-805,452.03A$0.00N/A
Cann AmericanN/AN/AN/AN/AN/A

Cann American has lower revenue, but higher earnings than Jayex Healthcare.

Summary

Jayex Healthcare beats Cann American on 1 of the 1 factors compared between the two stocks.

Jayex Healthcare (ASX:JHL) and CannaOne Technologies (OTCMKTS:CNONF) are both computer and technology companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, earnings, profitability, valuation and risk.

Earnings and Valuation

This table compares Jayex Healthcare and CannaOne Technologies' revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Jayex Healthcare$6.61 million0.00$-805,452.03A$0.00N/A
CannaOne TechnologiesN/AN/AN/AN/AN/A

CannaOne Technologies has lower revenue, but higher earnings than Jayex Healthcare.

Profitability

This table compares Jayex Healthcare and CannaOne Technologies' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Jayex HealthcareN/AN/AN/A
CannaOne TechnologiesN/AN/AN/A

Analyst Ratings

This is a breakdown of current ratings and price targets for Jayex Healthcare and CannaOne Technologies, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Jayex Healthcare0000N/A
CannaOne Technologies0000N/A

Summary

Jayex Healthcare beats CannaOne Technologies on 1 of the 1 factors compared between the two stocks.

Jayex Healthcare (ASX:JHL) and CloudMD Software & Services (OTCMKTS:DOCRF) are both computer and technology companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, earnings, analyst recommendations, valuation, profitability, dividends and institutional ownership.

Valuation and Earnings

This table compares Jayex Healthcare and CloudMD Software & Services' revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Jayex Healthcare$6.61 million0.00$-805,452.03A$0.00N/A
CloudMD Software & ServicesN/AN/AN/AN/AN/A

CloudMD Software & Services has lower revenue, but higher earnings than Jayex Healthcare.

Analyst Ratings

This is a summary of current ratings for Jayex Healthcare and CloudMD Software & Services, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Jayex Healthcare0000N/A
CloudMD Software & Services00203.00

CloudMD Software & Services has a consensus price target of $3.3750, suggesting a potential upside of 103.31%.

Profitability

This table compares Jayex Healthcare and CloudMD Software & Services' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Jayex HealthcareN/AN/AN/A
CloudMD Software & ServicesN/AN/AN/A


Jayex Healthcare Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
1st Group logo
1ST
1st Group
0.5N/AN/A$0.00$5.11 million0.00High Trading Volume
Gap Up
ALC
Alcidion Group
0.5N/AN/A$0.00$21.55 million0.00High Trading Volume
News Coverage
Gap Up
Binovi Technologies logo
BNVIF
Binovi Technologies
0.0$0.06flat$0.00N/A0.00Decrease in Short Interest
Gap Down
CNNA
Cann American
0.5N/AN/A$0.00N/A0.00High Trading Volume
CannaOne Technologies logo
CNONF
CannaOne Technologies
0.6$0.98flat$0.00N/A0.00Decrease in Short Interest
CloudMD Software & Services logo
DOCRF
CloudMD Software & Services
1.7$1.66flat$0.00N/A0.00Decrease in Short Interest
DOC
CloudMD Software & Services
1.2$2.02flatC$0.00C$11.65 million-22.44
CGS
Cogstate
0.5N/AN/A$0.00$28.82 million0.00High Trading Volume
Gap Up
COO
Corum Group
0.5N/AN/A$0.00$12.27 million0.00High Trading Volume
EGF Theramed Health logo
EVAHF
EGF Theramed Health
0.0$0.11flat$0.00N/A0.00Decrease in Short Interest
News Coverage
Gap Down
EMD
Emyria
0.6N/AN/A$0.00$1.73 million0.00High Trading Volume
Gap Up
EWLL
eWellness Healthcare
0.6$0.00flat$0.00N/A0.00
FORA
Forian
0.3$11.55flat$0.00N/A0.00Gap Up
GLH
Global Health
0.5N/AN/A$0.00$6.77 million0.00High Trading Volume
Gap Up
ICS
ICS Global
0.9N/AN/A$0.00$6.08 million0.00High Trading Volume
Gap Up
M3 logo
MTHRF
M3
1.0$76.00flat$0.00N/A0.00
M7T
Mach7 Technologies
0.6N/AN/A$0.00$16.89 million0.00High Trading Volume
Gap Up
MDR
MedAdvisor
0.5N/AN/A$0.00$18.09 million0.00High Trading Volume
Gap Up
NEWUF
Newtopia
1.7$0.41flat$0.00N/A0.00Gap Up
NHL
Novita Healthcare
0.5N/AN/A$0.00N/A0.00High Trading Volume
Gap Up
ONE
Oneview Healthcare
0.5N/AN/A$0.00$7.10 million0.00High Trading Volume
OPL
Opyl
0.0N/AN/A$0.00$741,494.000.00High Trading Volume
PCK
PainChek
0.0N/AN/A$0.00$240,424.000.00High Trading Volume
PANHF
Ping An Healthcare and Technology
1.0$12.20flat$0.00N/A0.00Gap Up
PKS
PKS
0.0N/AN/A$0.00$5.97 million0.00High Trading Volume
PME
Pro Medicus
0.7N/AN/A$0.00$59.12 million0.00High Trading Volume
Gap Up
Pro Medicus logo
PMCUF
Pro Medicus
0.5$35.65flat$0.00N/A0.00Decrease in Short Interest
RAP
ResApp Health
0.9N/AN/A$0.00$46,197.000.00High Trading Volume
Gap Up
CBIIF
Skylight Health Group
0.0$0.95flat$0.00N/A0.00News Coverage
TD1
TALi Digital
0.5N/AN/A$0.00$706,550.000.00High Trading Volume
UCBB
US-China Biomedical Technology
0.3$0.13flat$0.00N/A0.00
WELL Health Technologies logo
WLYYF
WELL Health Technologies
1.6$6.00flat$0.00N/A0.00
ZMD
ZoomMed
0.4$0.02flatC$0.00C$10,000.00-1.36Gap Down
This page was last updated on 4/16/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.